首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 78 毫秒
1.
大鼠同种异体肢体移植中T淋巴细胞亚群的变化及其意义   总被引:4,自引:2,他引:4  
目的 建立大鼠同种异体肢体移植模型,研究肢体移植中T细胞亚群的变化及其与急性排斥反应的关系。方法 将31只SD雄性大鼠随机分成两组,其中对照组14只为Wista→SD肢体移植术后不用药组,实验组17只为FK506(4mg/kg体重) RS-61443(30mg/kg体重)联合免疫抑制治疗组,观察各组移植术后排斥反应;用免疫荧光染色流式细胞仪检测各组手术前后T细胞亚群。结果 术后第3天,CD4/CDs比值显著增高,移植肢体开始出现肿胀、皮肤红斑等表现;CD4/CD8比值增高与排斥反应程度呈正相关,而用药组术后,CD4/CD8较术前无明显变化,未出现排斥反应。结论 T细胞亚群中CD4/CD8比值的变化与肢体移植急性排斥反应的发生、强烈程度有密切关系,可作为监测异体肢体移植急性排斥反应的免疫学指标。  相似文献   

2.
目的探讨大鼠异体肢体移植术后急性排斥反应阶段移植肢体血管内皮细胞损伤的病理形态学特征,凋亡及其意义。方法建立封闭群大鼠同基因组(Wistar→Wistar)(A组)和异基因组(SD→ wistar)(B组)肢体移植动物模型,异体肢体移植术后1、3、5、7、9 d,运用流式细胞仪测试外周血T淋巴细胞亚群动态变化;术后第1、4、7 d切取发生急性排斥反应肢体的股动、静脉1.0cm标本,行HE染色,光镜观察;原位末端标记(TUNEL)法检测移植肢体血管内皮细胞凋亡阳性细胞数。结果术后3 d外周血 CD4+增加显著,CD8+增加不明显,CD4+/CD8+比值明显升高,与术前和术后1 d比较差异有统计学意义 (P<0.01),术后5至9 d,CD4+/CD8+比值仍维持较高水平。血管HE染色提示内皮层在移植术后4 d出现内膜细胞连续性中断,EC表面不光滑,移植术后7 d,动脉各层有多量的淋巴细胞浸润,内膜层偶见梭形核细胞。异体移植术后1 d,4 d,7 d血管内皮细胞凋亡数分别为[(12.25±7.24)个,(X|-)±s,下同],(41.13± 8.53)个,(80.56±21.69)个。结论异体肢体移植术后急性排斥反应阶段,血管内皮细胞凋亡活性明显增高,提示细胞凋亡是大鼠肢体移植急性排斥反应期血管内皮细胞免疫损伤的主要原因之一。  相似文献   

3.
目的通过大鼠同种异体肢体移植模型,分析小剂量环孢素A(cyvlosporinA ,CsA)对大鼠同种异体肢体移植急性排斥反应的免疫抑制作用。方法采用雄性Wistar和SD大鼠为供、受体,以CsA为免疫抑制剂。对照组14只,将Wistar大鼠肢体移植至SD大鼠,术后不用药。实验组术后按用药剂量的不同分为2组( 2mg/kg组17只大鼠和CsA 6mg/kg组18只大鼠)。2组术后用药时间均为4周(每日1次共2周,然后每周2次共2周)。术后观察大鼠一般情况、移植肢体排斥反应及存活时间;用免疫荧光染色流式细胞仪检测各组手术前后T细胞亚群的变化。结果对照组移植肢体平均存活时间为[( 7.0 0±0 .78)d , x±s ,下同] ;CsA 2mg/kg组为( 3 7.18±0 .5 1)d ,CsA 6mg/kg组为( 3 3 .2 0±1.0 5 )d。术后第3天,对照组的CD4/CD8比值显著增高,移植肢体开始出现肿胀、皮肤红斑等表现。实验组的CD4/CD8较术前无明显变化。结论小剂量CsA能抑制大鼠同种异体肢体移植术后急性排斥反应的发生,并能延长移植肢体的存活时间。  相似文献   

4.
大鼠同种异体肢体移植急性排斥反应的实验研究   总被引:3,自引:0,他引:3  
目的通过大鼠同种异体肢体移植模型,旨在分析大鼠同种异体肢体移植中各种不同组织的急性排斥反应特点,确定反映肢体移植排斥反应最具有代表性的组织类型.方法将29只Sprague-Dawley成年大鼠随机分成2组,对照组15只为自体肢体再植组,实验组14只为Wistar→SD同种异体肢体移植组,术后不用免疫抑制剂,观察急性排斥反应出现的时间及表现,并对移植肢体中各组织进行组织病理学检查.结果异体肢体移植术后第(3.36±1.15)d开始出现皮下水肿和皮肤红斑,这是最早的急性排斥反应表表现;移植肢体的平均存活时间为(7±0.78)d;移植肢体中皮肤组织的排斥反应程度最强.结论Wistar→SD同种异体肢体移植中皮肤是最具有代表性的、最易于观察排斥反应的组织类型.  相似文献   

5.
目的探讨落新妇甙对大鼠肺移植后机体急性排斥反应的影响和机制,以明确落新妇甙对大鼠肺移植急性排斥反应的作用。方法建立大鼠原位肺移植模型,术后将60只受体大鼠随机分为两组,对照组:术后用生理盐水1ml/d灌胃,实验组:术后用落新妇甙1ml/kg·d灌胃。观察肺移植后大鼠的存活时间、大鼠脾细胞T淋巴细胞转化率、脾淋巴细胞白细胞介素2(IL-2)的活性以及外周血中活化T淋巴细胞凋亡情况。在电子显微镜下观察肺血管超微结构变化。结果实验组大鼠肺移植后存活时间较对照组明显延长(25.4±2.1d vs.13.4±1.2d;t=2.042,P〈0.05)。实验组脾细胞T淋巴细胞转化率较对照组明显降低(23465.8±8783.4 cpm vs.74567.3±12874.6cpm;t=2.284,P〈0.05);实验组移植大鼠脾淋巴细胞IL-2活性较对照组明显降低(4.25±2.65U/ml vs.23.46±1.82 U/ml;t=3.165,P〈0.01)。实验组能有效地诱导急性排斥反应中活化T淋巴细胞凋亡。实验组肺组织超微结构损伤较对照组减轻。结论落新妇甙通过下调IL-2产生,诱导活化T淋巴细胞凋亡,抑制T淋巴细胞增殖分化,广泛抑制了以T淋巴细胞为主的肺移植术后急性排斥反廊,从而延长肺移槽大鼠的存活时间.  相似文献   

6.
目的 探讨干预慢性迟发性超敏反应(DTH)与CD8^+T淋巴细胞的细胞毒等效应机制对同种小鼠心脏移植后慢性排斥反应的影响。方法 建立小鼠颈部异位心脏移植模型,实验组以BALB/c小鼠为供者,C57BL/6小鼠为受者,术后0、2、6及14d腹腔注射抗CD8单克隆抗体(抗CD8单抗)200μg/d,术后0、2及4d腹腔注射抗CD40L单克隆抗体(抗CD40L单抗)250μg/d;同系移植对照组供、受者均为BALB/C小鼠,术后同期腹腔注射等量生理盐水;同种移植对照组以BALWc小鼠为供者,C57BL/6小鼠为受者,术后不使用上述单抗。观察各组移植心的存活时间及移植心组织病理学变化。结果同种移植对照组移植心的平均存活时间为7.3d;实验组与同系移植对照组移植心的存活时间均超过60d。同种移植对照组移植心呈典型急性排斥反应病理学改变;同系移植对照组移植心组织未见明显病理变化;实验组移植心呈现血管周围炎、间质纤维化和血管内膜增生等慢性排斥反应组织病理改变。结论 清除CD8^+T淋巴细胞和阻断CD40/CD40L通路的处理方案虽可预防急性排斥反应,显著延长移植心的存活时间,但并不能阻止慢性排斥反应的发生。  相似文献   

7.
目的观察rhIL-10对小肠移植急性排斥反应和T细胞增殖的抑制作用。方法将移植后的大鼠随机分为同基因组、对照组和3种不同剂量的rhIL-10治疗组,各组n=6。术后3、5、7d取移植肠管,行病理检查,测外周血T细胞亚群及术后7d肝、肾功能的重要参数:天冬酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)、血肌酐(Crea)和血尿素(BUN)。结果对照组术后3d发生轻度排斥,5d发生中度排斥,7d发生重度排斥;中、高剂量组除部分标本在术后5、7d发生轻度排斥外,无排斥征象;低剂量组与对照组改变相似,但排斥的病理改变发生较晚、较轻。术后3、5、7d,低、中、高剂量组外周血CD3^+T细胞数及CD4^+/CD8^+比值与对照组比较差异有统计学意义(P〈0.05)。各组AST、ALT、Crea和BUN差异均无统计学意义(P〉0.05)。结论(1)对小肠移植急性排斥的抑制,低剂量作用是明确的,但疗效有限。中、高剂量作用较明显;与同基因组、对照组比较,不增加肝、肾毒副作用;(2)动态检测外周血CD3^+T细胞数及CD4^+/CD8^+比值可作为器官移植术后监测排斥反应的重要指标之一。  相似文献   

8.
耐受性树突状细胞延长大鼠移植脾存活时间   总被引:2,自引:0,他引:2  
目的 观察供者来源的耐受性树突状细胞(DC)在脾移植中的作用,并探讨其作用机理。方法 以Wista大鼠为供者,SD大鼠为受者,建立同种颈部异位脾脏移植模型。(1)分离供者的骨髓细胞,分别采用白细胞介素4(IL-4)和白细胞介素10(IL-10)诱导培养出成熟的DC和耐受性DC,并在光镜下观察两者的细胞形态学差别。采用流式细胞术检测两者对共刺激分子CD86表达的差异,采用混合淋巴细胞反应比较其在体外刺激同种异体T淋巴细胞增殖的反应能力。(2)将受者随机分成4组,每组10只。单纯移植组:受者不经任何预处理仅进行脾移植。IL-10DC组:在移植前7d经受者尾静脉注射2×10^6/ml的经IL-10诱导的DC 1 ml。IL-4 DC组:在移植前7d经受者尾静脉注射2×10^6/ml的经IL-4诱导的DC 1 ml。空白对照组:在移植前7d经受者尾静脉注射无细胞的培养液1ml。观察各组移植术后发生急性排斥反应的时间。结果 (1)经IL-10诱导的骨髓细胞表现为未成熟树突状细胞的形态和特性,细胞体积大,但少见树突状突起,细胞表面低表达CD86分子,不能有效刺激T淋巴细胞的增殖。而经IL-4诱导的骨髓细胞为典型的成熟树突状细胞,细胞胞体大,并有树突状突起,细胞表面高表达共刺激分子CD86,可显著刺激T细胞的增殖。(2)IL-10 DC组发生急性排斥反应的时间较其他3组明显延迟(P〈0.01);IL-4 DC组发生急性排斥反应的时间较单纯移植组和空白对照组明显提前(P〈0.05);而单纯移植组与空白对照组间则无明显差异(P〉0.05)。结论 应用供者来源的耐受性树突状细胞能够延缓大鼠移植脾急性排斥反应的发生时间。  相似文献   

9.
目的研究白细胞介素2(IL-2)在调节移植抗原特异性转基因CD8^+T细胞介导的免疫排斥反应中的作用。方法将经荧光染科CFSE标记后的C57BL/6小鼠和2CTg小鼠(CD4敲除鼠)淋巴细胞分别植入经致死剂量γ射线照射过的两组DBA/2J小鼠体内,检测CD4^+与CD8^+T细胞在体内分裂增殖的时相,并用胞浆内IL-2标志染色方法测定活化后T细胞表达IL-2的能力。以Balb/c小鼠为供者,糖尿病2CTg小鼠和2C Tg-IL-2KO小鼠(IL-2敲除鼠)为受者,进行胰岛细胞移植。观察CD8^+ T细胞在介导移植排斥中的作用。结果DBA/2J小鼠输注了C57BL/6小鼠的淋巴细胞后,CD4^+与CD8^+T细胞分裂增殖均非常明显,前者表达大量IL-2,后者则不表达。DBA/2J小鼠输注了2CTg小鼠的淋巴细胞后。在完全没有CD4^+T细胞存在的情况下,CD8^+T细胞仍明显分裂增殖并大量表达IL-2。2CTg和2CTg—IL-2KO小鼠移植胰岛细胞后,前者迅速发生排斥反应,胰岛移植物的平均存活时间仅为8d,而后者胰岛移植物的平均存活时间〉50d。结论CD8^+T细胞在产生和利用IL-2时有很大的可塑性。CD4^+T细胞存在时,CD8^+T细胞能有效利用CD4^+T细来源的IL-2进行分裂增殖,在缺乏CD4^+T细胞时,则利用自身来源的IL-2进行分裂增殖;移植抗原特异性CD8^+T细胞的效应功能完全依赖于IL-2,排斥反应由CD8^+T细胞介导时,阻断IL-2/IL-2受体通路可诱导移植物长期存活。  相似文献   

10.
目的探讨槐耳颗粒对小鼠心脏移植后移植物生存期的影响及其可能机制。方法槐耳颗粒在小鼠心脏移植术后每天予以6mg/g体重槐耳清膏灌胃处理;移植排斥对照组和同系移植对照组灌清水;术后5d或移植排斥终点收集供心做石蜡病理切片行HE染色及免疫荧光检查。结果移植排斥对照组供心平均存活时间为(8.0±0.53)d,槐耳颗粒组供心平均存活时间为(6.0±0.26)d,两组差异有统计学意义(P〈0.001)。槐耳颗粒组和移植排斥对照组供心心肌变性坏死、大量CD8^+T细胞浸润及FasL表达。而同系移植对照组阴性。结论小鼠心脏移植术后槐耳清膏灌胃移植物生存期缩短,其可能与其增强CD8^+T细胞浸润及FasL表达有关。  相似文献   

11.
There are some names that are well known in pediatric anesthesia but who were these people? For 60 years before work stations appeared, the Ayre’s T Piece was widely used. Appropriately initialed, T.P. Ayre (Philip) ( Figure 1 ) was a Newcastle anesthetist who gave several hundred anesthetics as a student, so it was natural that he should become an anesthetist. Ayre’s T Piece was developed about 1937. It allowed fresh gas to be delivered to an endotracheal tube, allowing the anesthetist to be distanced from the operative field. The original T Piece was derived from part of a Phillips airway, which Ayre had been using. It had a bend in the side arm within the lumen of the connecting tube so that the gas could be delivered flowing toward or away from the patient. Ayre soon realized that patients did better when the flow was directed toward the patient. He thought that this aided inspiration. More importantly, although he may not have understood the reason, it kept the airways open preventing alveolar collapse and a reduction in functional residual capacity (FRC). This was unwittingly the first step in the development of the use of positive end expiratory pressure (PEEP). However, when it came to manufacturing the T piece, the makers preferred the simplicity of a tube attached at right angles to the airway ( Figure 2 ), and hence, the advantage was lost until an angled side arm was developed.
Figure 1 Open in figure viewer PowerPoint T. Philip Ayre.  相似文献   

12.
13.

Background

The immediate radical re-resection (IRR) after simple cholecystectomy in incidental gallbladder carcinoma (IGBC) is debated in the literature. The German S3 guidelines recommend IRR in T2 and more advanced stages. Current literature recommends more extensive surgery even in T1b tumors.

Methods

The German registry database was used for this study.

Results

To date 883 cases of IGBC have been analyzed. In 8 out of 39 patients with a T1a tumor IRR was carried out as well as in 43 out of 109 patients with a T1b tumor. There was a significant survival benefit for re-resected T1b patients. There was also a significant survival benefit for the 215 T2 tumors and the 75 T3 patients with IRR compared to the 441 T2 tumors and 207 T3 tumors without IRR. Comparison of liver resection techniques showed good results for the wedge resection technique in T1b and T2 carcinomas. For T3 carcinomas more radical techniques showed better results. Less than 50?% of T2–3 tumors in the registry have been re-resection.

Conclusions

The IRR should be highly recommended in patients with T1b and more advanced IGBC. The wedge resection technique is an attractive procedure for T1b and T2 IGBC due to the lower invasiveness in spite of oncological adequacy.  相似文献   

14.
15.
16.
17.
Management of stage T3 and T4 glottic carcinomas   总被引:1,自引:0,他引:1  
Between 1959 and 1979, 242 patients with T3 and T4 lesions of the vocal cords were treated at our institution. Treatment consisted of total laryngectomy in all patients. Different modalities of regional node dissections were performed on 187 patients. In addition, 50 patients received irradiation with cobalt-60 postoperatively for specific features of the disease. In the group of 192 patients whose treatment consisted of surgery alone, 28 (14 percent) had recurrence in the neck and 10 (5 percent) had stomal recurrence. Of the patients treated with combined therapy, three (6 percent) had ipsilateral neck recurrences and one (2 percent) had stomal recurrence. For lesions staged N0, failure rates above the clavicles were 16 percent and 31 percent for patients with T3 and T4 lesions, respectively, in the group treated by surgery alone, 9 percent and 6 percent for patients with T3 and T4 lesions, respectively, in the combined therapy group. The rate of failure above the clavicles for lesions staged N+ was 32 percent in the group treated with surgery alone and 8 percent in the combined therapy group. In this study, a correlation was made between the failure rates above the clavicles and different clinical and histologic characteristics of the tumor, surgical findings, and the different modalities of cervical node dissection used. From analysis of the data, recommendations have been made for the selective treatment of patients with advanced glottic carcinomas.  相似文献   

18.
19.
Although radical resection is the best treatment for local aggressive benign tumors or malignant tumors of the spine, total spondylectomy for lower thoracic vertebrae may cause anterior spinal artery syndrome. There are few reports in the literature in which this syndrome has been documented in association with thoracic spondylectomy, although this syndrome is the most common neurologic complication after abdominal aortic surgery. A 50-year-old woman with a giant cell tumor of the thoracic vertebrae was treated by posterior and anterior surgery. Thoracic segmental arteries from T10 to T12 had to be resected bilaterally to dissect the aorta free from the tumor. After resection of all feeding arteries to the tumor, the tumor and entire parts of T10, T11, and T12 were removed. Postoperative neurologic examination disclosed flaccid paralysis of the lower extremities and sphincter incontinence. Although pain and temperature sensation were absent, vibration and position sense were intact, showing anterior spinal artery syndrome. Intraoperative somatosensory-evoked potential monitoring only showed that transient deterioration failed to adequately reflect this neurologic injury. Major reconstructive surgery involving lower thoracic regions may cause anterior spinal artery syndrome. Somatosensory-evoked potential monitoring might not reliably predict overall neurologic outcome involving the blood supply of the lower thoracic regions.  相似文献   

20.
Lung cancer invading neighboring anatomical structures such as the chest wall, pericardium, diaphragm, and left atrium are categorized as T3 or T4, which is regarded as locally advanced lung cancer. The purpose of this study was to evaluate results of surgical treatment of T3-4N0-2M0 non-small cell lung cancer according to involved organs. From 1981 to April 2005, 148 patients with lung cancer invading neighboring organs were surgically treated in our hospital. The 5-year survival was 41.4% in all cases. According to 5-year survival of clinical characteristics, the chest wall (parietal pleura) group (45.5%) had a significantly better prognosis compared with the left atrium (0%, p = 0.03) and diaphragm (0%, p = 0.04) groups. T3N0 (50.3%), IIB (55.4%), IIIA (44.6%), and complete resection groups (49.0%) showed a significantly better prognosis compared with T3N2 (27.9%, p = 0.01), III B (0%, p < 0.0001), and incomplete resection groups (13.9%, p < 0.0001), respectively. These results indicate that the prognosis of patients with N2 disease or incomplete resection remains poor in regardless with the type of involved organs.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号